Efficacy of intramyometrial versus intravenous oxytoci

Phase 3

• Conditions: To prevent postpartum hemorrhage in pregnant women that scheduled for elective cesarean section then oxytocin will be administrated to stimulate uterine contraction.; oxytocin; intramyometrial; intravenous; elective cesarean section; uterine atony

• Registration Number: TCTR20210914002
• Lead Sponsor: Faculty of Medicine Siriraj Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-09-14
• Study Completion: 2022-04-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

1.pregnant women who came for elective cesarean section at Siriraj Hospital
2.gestational age at 34 weeks or more

Exclusion Criteria

1. In active phase if labor
2. Hematologic disorder that effect bleeding tendency
3. Contraindication for oxytocin
4. Allergy to oxytocin or its composition
5.Obstetric condition that risk for bleeding such as placenta previa, preeclampsia
6.Fetal anomalies
7. Fetal death
8. Conduct general anesthesia for Cesarean section

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Estimated blood loss 24 hours postpartum Visual estimation of operative blood loss

Secondary Outcome Measures

Name	Time	Method
pregnancy outcomes 7 days Data from chart,Additional uterotonic agent During operative time and 24 hours postpartum Data from intraoperative record,Side effect of oxytocin 24 hours postpartum Interview for known and unknown adverse effects ,Hematocrit 24 hours postpartum Collect blood at 24 hours postpartum and measure for CBC